Delivery Order SPE2DB24D2208-SPE2DB25FHHDG

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Firm Fixed Price Delivery Order valued at $4,626.77. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of January 15, 2025. The award is for the provision of ENBREL 50 MG/ML SURECLICKML, a specialty medication. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $59,037.06 awarded by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) for pharmaceutical products and medical supplies. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of medications and medical commodities to support military healthcare programs globally. The contract covers a variety of pharmaceutical and medical...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA). The $5,872.81 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of January 31, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,097.34 firm fixed-price delivery order is for the supply of Enbrel 50 mg/mL SureClick medication. The contract has a completion date of July 17, 2024. This award is a child under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Enbrel 50 mg/mL SureClick medication. The $34,604.54 firm fixed-price delivery order has a completion date of November 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,562.38 firm fixed-price delivery order contract is for the provision of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Enbrel 50 mg/mL SureClick medication. The contract is a Delivery Order with a Firm Fixed Price of $16,399.14 and has an ultimate completion date of July 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of ENBREL 50 MG/ML SURECLICKML medical supplies. The $9,253.56 firm fixed price delivery order was awarded on January 23, 2025 by the Defense Logistics Agency (DLA), with a completion date of January 24, 2025. The contract has no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,346.84 firm fixed-price delivery order is for ENBREL 50 MG/ML SURECLICK, a specialty medication. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $4,979.18 awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication, with an ultimate completion date of December 3, 2024. The contract is a firm fixed-price arrangement. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB25FHHDG
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Enbrel 50 mg/mL Sureclick medical supplies. The $16,394.75 firm-fixed-price delivery order has a completion date of February 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/9/25, 10:11 AM